RG

Rethinam Ganesan

Director Director DIN 06845674
DIN 06845674 First appointment May 2014 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since May 2014
Shareholding value Locked Premium profile

About Rethinam Ganesan

Rethinam Ganesan has 12 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

DIN 06845674
Primary Designation Director
First Appointment 03 May 2014
Oldest Company Age 13 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Artenda Pharmaceuticals Private Limited U33111TN2013PTC091517
Director 03 May 2014 2013 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Artenda Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rethinam Ganesan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rethinam Ganesan

Rethinam Ganesan has 12 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

Rethinam Ganesan is associated with 0 companies as Director.

Rethinam Ganesan has expertise in General Business.

Rethinam Ganesan has 12 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available